Troy E. Wilson

Insider Reports History

Entity
Individual
Location
C/O Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400, San Diego, CA
Signature
/s/ Gordon Esplin as attorney-in-fact for Troy E. Wilson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Troy E. Wilson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kura Oncology, Inc. President and CEO, Director Common Stock 300K $6.07M $20.23 Jan 24, 2024 by Lorax Charitable Remainder Unitrust
Kura Oncology, Inc. President and CEO, Director Common Stock 279K $5.65M $20.23 Jan 24, 2024 by One Fish Two Fish Revocable Trust
Avidity Biosciences, Inc. Director Common Stock 300K $3.04M $10.13 Dec 12, 2023 By trust FBO Children 1 and 2
Avidity Biosciences, Inc. Director Common Stock 300K $3.04M $10.13 Dec 12, 2023 By trust FBO Children 3 and 4
Avidity Biosciences, Inc. Director Common Stock 62.7K $635K $10.13 Dec 12, 2023 Direct
Avidity Biosciences, Inc. Director Common Stock 35.6K $360K $10.13 Dec 12, 2023 By trust FBO Child 1
Avidity Biosciences, Inc. Director Common Stock 35.6K $360K $10.13 Dec 12, 2023 By trust FBO Child 2
Avidity Biosciences, Inc. Director Common Stock 13.7K $139K $10.13 Dec 12, 2023 By family trust
Avidity Biosciences, Inc. Director Common Stock 11.9K $120K $10.13 Dec 12, 2023 By trust FBO Child 3
Avidity Biosciences, Inc. Director Common Stock 11.9K $120K $10.13 Dec 12, 2023 By trust FBO Child 4
PUMA BIOTECHNOLOGY, INC. Director Common Stock 27.4K $91.1K $3.33 Jun 18, 2024 Direct
Kura Oncology, Inc. President and CEO, Director Common Stock 559 $11.3K $20.23 Jan 24, 2024 Direct
PUMA BIOTECHNOLOGY, INC. Director Common Stock 400 $1.33K $3.33 Jun 18, 2024 By Child #1
PUMA BIOTECHNOLOGY, INC. Director Common Stock 150 $499 $3.33 Jun 18, 2024 By Child #2
Kura Oncology, Inc. President and CEO, Director Option to purchase common stock 560K Jan 2, 2024 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 13.5K Jun 13, 2024 Direct

Insider Reports Filed by Troy E. Wilson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PBYI PUMA BIOTECHNOLOGY, INC. Jun 18, 2024 1 $0 4 Jun 21, 2024 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2024 1 -$89.9K 4 Jun 17, 2024 Director
RNA Avidity Biosciences, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
KURA Kura Oncology, Inc. Jan 24, 2024 4 -$1.29M 4 Jan 26, 2024 President and CEO, Director
KURA Kura Oncology, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Dec 12, 2023 4 $0 4 Dec 14, 2023 Director
KURA Kura Oncology, Inc. Dec 7, 2023 2 $0 4 Dec 11, 2023 President and CEO, Director
RNA Avidity Biosciences, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2023 2 -$93.3K 4 Jun 15, 2023 Director
KURA Kura Oncology, Inc. Jun 2, 2023 8 $0 4 Jun 2, 2023 President and CEO, Director
KURA Kura Oncology, Inc. Jul 14, 2022 8 $0 4 Feb 21, 2023 President and CEO, Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 16, 2022 1 -$72K 4 Jun 21, 2022 Director
RNA Avidity Biosciences, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
KURA Kura Oncology, Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 President and CEO, Director
RNA Avidity Biosciences, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 10, 2021 1 -$292K 4 Jun 11, 2021 Director